Searched for
CHIGURUPATI
Drugmaker Granules to tighten oversight after US FDA warning, executive saysThe company, which is globally one of the largest paracetamol makers and a major player in the active pharmaceutical ingredients market, de...- Indian drugmaker Granules to tighten oversight after US FDA warning, exec saysAmid growing scrutiny from the U.S. FDA over documentation practices and contamination issues, Granules India is reinforcing its manufactur...
- Hyderabad doctor orders drugs worth Rs 5 lakh on WhatsApp, arrestedIn Hyderabad, Doctor Namrata Chigurupati was arrested. She allegedly purchased cocaine worth Rupees 5 lakh. Police caught her receiving the...
- Granules promoter Chigurupati sells stakeAbout 75 lakh shares worth 303.81 crore were sold at 405.08 apiece and were bought by 8 funds at 405-405.1. Axis MF, Massachusetts Institut...
- Granules India earmarks capex of Rs 1,000 crore till FY24The Hyderabad-based firm plans to invest in a new manufacturing facility and on expanding production capacities at existing plants.
- Buy Granules India, price target Rs 160: Jayesh BhanushaliThe analyst suggested a stoploss at Rs 142.
- Buy Granules India, target Rs 116: Manas JaiswalBuy Granules India Ltd. at a price target of Rs 116.0 and a stop loss at Rs 107.5 from the entry point.
- Buy Granules India, target Rs 140: Chandan TapariaBuy Granules India Ltd. at a price target of Rs 140.0 and a stop loss at Rs 128 from entry point.
- Buy Granules India, target Rs 128: Kunal BothraBuy Granules India at a price target of Rs 128 and a stop loss at Rs 117 from entry point.
- Buy Granules India, target Rs 160.0 : Nirmal Bang SecuritiesBuy Granules India Ltd. at a price target of Rs 160.0 and a stop loss at Rs 149.0 from entry point
- Zenotech MD gets CLB nod to sell 10% in Daiichi open offerThe Company Law Board (CLB) has allowed Zenotech Laboratories’ founder and managing director Jayaram Chigurupati to sell a part of his 25% ...
- 'Zenotech can't reappoint board members without permission'The key body responsible for settling corporate disputes has told Zenotech Laboratories that it cannot reappoint two board members without ...
- Ranbaxy loses to Zenotech in CLBIn a setback to India’s largest drugmaker Ranbaxy, the Company Law Board (CLB) has upheld the appointment of two directors on the board of ...
- Ranbaxy loses to Zenotech in Company Law BoardIn a setback to India’s largest drug maker Ranbaxy, the Company Law Board (CLB) has upheld the appointment of two directors on the board of...
- CLB halts board meeting of Zenotech LaboratoriesThe Company Law Board (CLB) on Thursday stopped Hyderabad-based Zenotech Laboratories from holding its board meeting on Friday.
- Ranbaxy, Zenotech lock horns over board directorsRanbaxy told the Company Law Board that Zenotech's founder MD Jayaram Chigurupati has no right to appoint the directors as he was attemptin...
- Ranbaxy-Zenotech lock horns over board directorsRanbaxy Laboratories has objected to the appointment of two new directors to the board of Zenotech Laboratories, continuing a battle of att...
- Zenotech told to hold board meeting on August 19The founder of Zenotech Laboratories Jayaram Chigurupati managed to secure a minor victory from the Company Law Board (CLB), a day after mi...
- Daiichi sticks to open offer price for ZenotechDaiichi Sankyo, the new promoter of Ranbaxy, said it would not increase the open offer price of Rs 113.62 to buy a 20% stake in Hyderabad-b...
- Daiichi not to up open offer price to buy stake in ZenotechDaiichi Sankyo will not increase the open offer price of Rs 113.62 to buy 20% stake in Hyderabad-based Zenotech Labs.
Load More
